Building figures for grants, papers and presentations with Biorender...and you might get a free license: we don't leave any opportunity out #BioRenderForGrants

🌟 Proud to share the new Recurrent FSGS Foundation logo! Its repeating pattern represents the difficult journey of disease recurrence—and our mission to end that cycle. Website, mission, and ways to get involved coming soon. #RecurrentFSGS

Incredibly grateful for the @rFSGSInitiative giving me the opportunity to speak on the panel about recurring #FSGS a club that we never asked to join. Appreciate everyone who came to DC. Lots of hugs, emotions, & tears. This is exactly what I needed. #motivated

A great panel discussion after a terrific keynote presentation by @Moinsaleem , moderated by @AstridWeins @rFSGSInitiative @SannaCherchiLab @GbadegesinLab

Small-cohort GWAS discovery with AI over massive functional genomics knowledge graph | ⁦@medrxivpreprint⁩

We've kicked off the first-ever #rFSGSConference! We look forward to an impactful day by and for #rFSGS patients. #RareDisease #KidneyTransplant

@sidsdoc @ShriThanedar @rFSGSInitiative @SannaCherchiLab @GbadegesinLab @priyagoose @AstridWeins @Kidney_Int @rupeshrainamd @jradnephro You bet. Dr. Debbie Gipson from @NIDDKgov shared this in the first scientific PowerPoint

Nephrology is one of the pediatric subspecialties with the largest workforce shortage in the US. This study found that children residing in states with higher pediatric nephrologist density had better access to waitlist registration, especially preemptively, and deceased donor

https://t.co/6UkI2iqXPZ

Freshly published in @JASN_News ! Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM @OpeyemiOlabisi8 @GbadegesinLab @H3Africa @AfricanAFRAN @ASNKidney @ISGDtweets @ApolloNetwork13

A few more days to register to the first ever, recurrent FSGS conference !! If you are not blown away by the program, come for the food :) #rFSGS #FSGS #raredisease @ASNKidney @ASPNeph @ISGDtweets @nephcure

Follow our @rFSGSInitiative ! And learn about the up and coming conference at Capitol Hill in Washington DC. Register and come form with us a community of patients, researchers, and advocates to fight and resolve recurrent #FSGS Look below to register ⬇️ ⬇️ ⬇️ ⬇️ ⬇️

The #rFSGS Meeting in DC, December 9th is close and keeps gaining traction! We upsized the room venue, there is still time for you to come !!! There is still time to register! Don't miss it! https://t.co/11q8i0uFZ3… #FSGS #rFSGS #RareDisease #genetics #NephTwitter

I had the pleasure of attending this presidential address in person! By far one of the best, funniest, but mostly, important divulgative talks I’ve ever attended to. We all know and met super chicken, perhaps wanted to be super chicken at times, but collective intelligence and

Diabetic kidney disease (DKD) is a serious complication of diabetes and a major cause of kidney failure. In this issue of JASN, Cooper et al. investigated the effects of VEGF-B inhibition in patients with DKD in a phase 2A clinical trial. In this editorial, Dr. Rhian Touyz argues

👏👏👏🎉🎉🎉

For patients and families! Our recurrent FSGS #rFSGS meeting will gather dozen of families and top researchers and clinicians in the field of #nephroticsyndrome #FSGS and #rFSGS. There is still time to register! Don't miss it! https://t.co/AJeVOepdcS #FSGS #rFSGS #RareDisease

Josh Tarnoff, CEO of @nephcure will be at the first ever #rFSGS Conference! Join us to this exciting event featuring researchers, patients, industry, political figures, and more..... December 9th, Washington DC! Register here https://t.co/AJeVOepdcS @ISGDtweets @ASNKidney

Great opportunity to get your best research evaluated timely and, hopefully, published in JASN #NephTwitter

Targeting a toxic repeat: https://t.co/qGoIrKHRHp ASCI member Jiou Wang & team target translation of the expanded GGGGCC RNA repeat in models of amyotrophic lateral sclerosis and frontotemporal dementia using CRISPR technology. @JohnsHopkinsBMB